Tag: type 2 diabetes
Pooled analysis of over 18,000 participants supports benefits of finerenone across...
A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events...
Semaglutide reduces risk for major kidney disease events in patients with...
Findings from the FLOW trial, the first dedicated kidney outcomes trial with a glucagon-like peptide-1 (GLP-1) receptor agonist were reported at a symposium at...
World’s first successful genetically-edited pig kidney transplant performed in US
A recent attempted transplant of a genetically-edited pig kidney has been successfully carried out for the first time at Massachusetts General Hospital (MGH) in...
FLOW trial shows reduction in kidney disease progression in patients with...
Novo Nordisk has announced via press release the headline results from the kidney outcomes trial FLOW, coming after the decision to stop the trial...
MultiOmic Health and Queen’s University Belfast collaborate for future of diabetic...
MultiOmic Health has partnered with the Centre for Public Health at Queen’s University Belfast (QUB) on a collaborative project to develop data-driven diagnostic tools...
New option for chronic kidney failure patients emerges as Ozempic trial...
Ozempic (Novo Nordisk) is a once-daily injection with US Food and Drug Administration (FDA) approval for use as a preventative treatment for strokes and...
Shares drop for dialysis providers as Ozempic kidney failure study’s early...
In early October, Novo Nordisk announced they will stop the kidney outcomes trial FLOW at interim, after initial results and the recommendation from the...
Finerenone to be trialled for CKD in type 1 diabetes patients
Bayer has announced the initiation of FINE-ONE, a global, multicentre, randomised, placebo-controlled, double-blind, parallel-group Phase III study to evaluate the efficacy and safety of...